{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:56Z","timestamp":1786985816943,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120650","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:22:09Z","timestamp":1760030529000},"page":"120650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Laboratory diagnostic in multiple myeloma: Quantification of daratumumab blood levels using isoelectric focusing"],"prefix":"10.1016","volume":"579","author":[{"given":"Rieke","family":"Reiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang Andreas","family":"Nockher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120650_bb0005","first-page":"13","article-title":"CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt\/protein kinase B and Erk activation in the absence of the CD3-\u03b6 immune receptor tyrosine-based activation motifs","volume":"277","author":"Zubiaur","year":"2002","journal-title":"J. Biol."},{"key":"10.1016\/j.cca.2025.120650_bb0010","doi-asserted-by":"crossref","first-page":"56598","DOI":"10.18632\/oncotarget.17896","article-title":"Expression of CD38 in myeloma bone niche: a rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation","volume":"8","author":"Costa","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2025.120650_bb0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/14712598.2020.1806231","article-title":"Daratumumab subcutaneous formulation for the treatment of multiple myeloma","volume":"20","author":"Paul","year":"2020","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.cca.2025.120650_bb0020","doi-asserted-by":"crossref","first-page":"7891","DOI":"10.2147\/CMAR.S212526","article-title":"Evaluating daratumumab in the treatment of multiple myeloma: safety, efficacy and place in therapy","volume":"12","author":"Dima","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.cca.2025.120650_bb0025","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1515\/cclm-2025-0352","article-title":"Beyond the Hydrashift assay: the utility of isoelectric focusing for therapeutic antibody and paraprotein detection","volume":"63","author":"Reiter","year":"2025","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2025.120650_bb0030","author":"European Medicines Agency"},{"key":"10.1016\/j.cca.2025.120650_bb0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40262-023-01240-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of daratumumab","volume":"62","author":"Kim","year":"2023","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cca.2025.120650_bb0040","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s12325-018-0815-9","article-title":"Pharmacokinetics and exposure\u2013response analyses of daratumumab in combination therapy regimens for patients with multiple myeloma","volume":"35","author":"Xu","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.cca.2025.120650_bb0045","author":"European Medicines Agency"},{"key":"10.1016\/j.cca.2025.120650_bb0050","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00216-018-1561-1","article-title":"A generic workflow for the characterization of therapeutic monoclonal antibodies \u2013 application to daratumumab","volume":"411","author":"Duivelshof","year":"2019","journal-title":"Anal. Bioanal. Chem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125005297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125005297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:37:17Z","timestamp":1766511437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125005297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":10,"alternative-id":["S0009898125005297"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120650","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory diagnostic in multiple myeloma: Quantification of daratumumab blood levels using isoelectric focusing","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120650"}}